- 返回 |
- HOME
- / NEWS & EVENTS
- / Industry News
- / Introduction to the innovative anti-HIV drug Albuvirtide - 1417179-66-8
Introduction of Albuvirtide, a cutting-edge biological anti-HIV innovative drug
Frontier Biology was founded in 2013, the company is committed to research and development, development, production and sales of new drugs with major clinical needs, is based in China for the world, with international competitiveness of innovative biologics enterprises, in the field of HIV long-term treatment and immunotherapy has strong competitiveness.
The company's 16 years of independent research and development of Ebovitai (trade name: Aconine) is the first anti-AIDS new drug in China, but also the world's first approved long-term HIV fusion inhibitor, has been listed in Ecuador, and has been patented in China, the United States, Japan, Europe and other major markets.
| 英文名称: | L-Leucine, L-tryptophyl-L-α-glutamyl-L-α-glutamyl-L-tryptophyl-L-α-aspartyl-L-arginyl-L-α-glutamyl-L-isoleucyl-L-asparaginyl-L-asparaginyl-L-tyrosyl-L-threonyl-N6-[2-[2-[2-[[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]amino]ethoxy]ethoxy]acetyl]-L-lysyl-L-leucyl-L-isoleucyl-L-histidyl-L-α-g... |
| 英文同义词: | Albuvirtide;L-Leucine, L-tryptophyl-L-α-glutamyl-L-α-glutamyl-L-tryptophyl-L-α-aspartyl-L-arginyl-L-α-glutamyl-L-isoleucyl-L-asparaginyl-L-asparaginyl-L-tyrosyl-L-threonyl-N6-[2-[2-[2-[[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]amino]ethoxy]ethoxy]acetyl]-L-lysyl-L-leucyl-L-isoleucyl-L-histidyl-L-α-g... |
| CAS号: |
Official Applets
Follow Us
021-64541543
Room 705-707, Building 2, 245 Jiachuan Road, Xuhui District, Shanghai
9：00-17：30